The Department of Defense (DoD) has entered into a $3.1 million agreement with bioMerieux's BioFire Defense subsidiary to increase manufacturing capacity for COVID-19 test kits. The company will use the investment to install two
We use cookies to offer you a better browsing experience, analyze site traffic, personalize content, and serve targeted advertisements. Read about how we use cookies and how you can control them on our Privacy Policy. If you continue to use this site, you consent to our use of cookies.